News/announcements

 

AGM Statement - Trading update

At today’s Annual General Meeting of the Company, the following trading update is being given by the Chairman, Ian Johnson.

Read more

Results of 2017 Annual General Meeting

The Board announces that the Annual General Meeting of the Company was held this morning. 

Read more

PDMR Dealing

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Read more

Issue of shares and Total Voting Rights

Bioquell PLC announces that it has issued 5,087 Ordinary Shares of 10p each following the exercise of options under the Company's share option schemes.

Read more

PDMR Dealing, exercise of share options and issue of new ordinary shares

Bioquell PLC announces that it has issued 36,511 ordinary shares of 10p each following the exercise of options under the Company's share option and SAYE schemes. 

Read more

Directorate Change

Bioquell announces that it has accepted the resignation of Tony Bourne as a non-executive director, to take effect from the Company’s AGM on 26th April.

Read more

Directorate Change

Bioquell announces that it has accepted the resignation of Tony Bourne as a non-executive director, to take effect from the Company’s AGM on 26th April.

Read more

Notice of AGM 2017

The Annual General Meeting (“AGM”) of Bioquell PLC (“Bioquell” or “the Company”) will take place on Wednesday 26th April 2017 at the Company’s offices, 52 Royce Close, West Portway, Andover, Hampshire, SP10 3TS. The Meeting will start at 12.00 noon. The formal Notice of the AGM and the Form of Proxy are available for download – please follow the links below. 

Read more

Annual Report

Following the preliminary announcement issued on 7 March 2017, the full electronic version of the BIOQUELL annual report is now available to download in PDF format on the Company’s website at www.bioquellplc.com.

Read more

Purchase of own shares

Further to the Company’s announcement on 13 March 2017 stating its intention to reduce its capital by means of purchasing its shares from time to time using existing cash resources, the Company announces that on 13 March 2017 it purchased 25,000 of its ordinary shares on the London Stock Exchange at a price of 135 pence per share. The purchased shares will all be held as treasury shares.

Read more